Author: | Slovin, S. F. |
Article Title: | Fifth International Prostate Cancer Congress. 1-3 July 2005, Rio Grande, Puerto Rico |
Abstract: | This is an extraordinary time for the treatment of localized and metastatic prostate cancer as manifested by the multi-disciplinary and multi-modality approaches being incorporated into standard technologies. While this is merely a highlight of the current state-of-the-art processes, and does not reflect the importance of any one approach as being superior to the next, the information shared at this meeting will continue to provide a platform, which will establish more diverse treatments. This will not only impact on the disease itself, but may help delay time-to-radiographic progression and improve overall survival. © The Thomson Corporation. |
Keywords: | unclassified drug; histone deacetylase inhibitor; prednisone; thalidomide; clinical trial; neutropenia; bevacizumab; drug efficacy; drug safety; nonhuman; antineoplastic agents; drug approval; conference paper; paclitaxel; antineoplastic agent; prostate specific antigen; animals; imatinib; carboplatin; bone marrow suppression; kidney disease; neuropathy; neoplasm proteins; calcitriol; antineoplastic activity; drug structure; docetaxel; prostate cancer; prostatic neoplasms; drug mechanism; membrane glycoproteins; granisetron; liver disease; histone deacetylases; retinoic acid; 2 methoxyestradiol; ixabepilone; epothilone b; atrasentan; pyrrolidines; ispinesib; satraplatin; e 7389; leflunomide |
Journal Title: | IDrugs |
Volume: | 8 |
Issue: | 9 |
ISSN: | 1369-7056 |
Publisher: | Thomson Reuters (scientific) Ltd |
Date Published: | 2005-09-01 |
Start Page: | 710 |
End Page: | 712 |
Language: | English |
PUBMED: | 16118688 |
PROVIDER: | scopus |
DOI/URL: | |
Notes: | --- - "Export Date: 24 October 2012" - "CODEN: IDRUF" - "Source: Scopus" |